$AVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMAG PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AMAG PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 7 8 9 10 11
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.06 | 48 | 1,203 | 634,522 | 634.6 K to 634.5 K (-0.01 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.28 | 240 | 6,067 | 634,570 | 634.8 K to 634.6 K (-0.04 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.29 | 480 | 12,139 | 634,810 | 635.3 K to 634.8 K (-0.08 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.30 | 288 | 7,286 | 635,290 | 635.6 K to 635.3 K (-0.05 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.25 | 1,200 | 30,300 | 635,578 | 636.8 K to 635.6 K (-0.19 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.26 | 96 | 2,425 | 636,778 | 636.9 K to 636.8 K (-0.02 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.35 | 192 | 4,867 | 636,874 | 637.1 K to 636.9 K (-0.03 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.10 | 336 | 8,434 | 637,066 | 637.4 K to 637.1 K (-0.05 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.13 | 48 | 1,206 | 637,402 | 637.5 K to 637.4 K (-0.01 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.12 | 240 | 6,029 | 637,450 | 637.7 K to 637.5 K (-0.04 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.15 | 1,200 | 30,180 | 637,690 | 638.9 K to 637.7 K (-0.19 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.41 | 2,296 | 58,341 | 638,890 | 641.2 K to 638.9 K (-0.36 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.20 | 2,295 | 57,834 | 641,186 | 643.5 K to 641.2 K (-0.36 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.23 | 2,296 | 57,928 | 643,481 | 645.8 K to 643.5 K (-0.36 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.35 | 13,773 | 349,146 | 645,777 | 659.6 K to 645.8 K (-2.09 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.31 | 2,295 | 58,086 | 659,550 | 661.8 K to 659.6 K (-0.35 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.11 | 2,296 | 57,653 | 661,845 | 664.1 K to 661.8 K (-0.35 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.02 | 2,295 | 57,421 | 664,141 | 666.4 K to 664.1 K (-0.34 %) |
| Mar 02 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.07 | 2,296 | 57,561 | 666,436 | 668.7 K to 666.4 K (-0.34 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.51 | 2,500 | 63,775 | 668,732 | 671.2 K to 668.7 K (-0.37 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.50 | 7,500 | 191,250 | 671,232 | 678.7 K to 671.2 K (-1.11 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.49 | 2,500 | 63,725 | 678,732 | 681.2 K to 678.7 K (-0.37 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.44 | 2,500 | 63,600 | 681,232 | 683.7 K to 681.2 K (-0.37 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.34 | 2,500 | 63,350 | 683,732 | 686.2 K to 683.7 K (-0.36 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.40 | 2,500 | 63,500 | 686,232 | 688.7 K to 686.2 K (-0.36 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.35 | 7,000 | 177,450 | 688,732 | 695.7 K to 688.7 K (-1.01 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.30 | 1,800 | 45,540 | 695,732 | 697.5 K to 695.7 K (-0.26 %) |
| Feb 23 2006 | AVM | AMAG PHARMACEUTICA ... | GREAT POINT PARTNERS LLC | 10% Owner | Sell | S | 25.31 | 700 | 17,717 | 697,532 | 698.2 K to 697.5 K (-0.10 %) |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | STEINMAN THEODORE I | Director | Option Exercise | A | 19.98 | 2,000 | 39,960 | 2,000 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | A | 19.98 | 2,000 | 39,960 | 2,000 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | A | 19.98 | 2,000 | 39,960 | 2,000 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President | Option Exercise | A | 0.00 | 20,000 | 0 | 0 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President | Option Exercise | A | 19.98 | 100,000 | 1,998,000 | 100,000 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 19.98 | 2,000 | 39,960 | 2,000 | |
| Feb 09 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | A | 19.98 | 2,000 | 39,960 | 2,000 | |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.40 | 43,570 | 670,978 | 985,163 | 1 M to 985.2 K (-4.24 %) |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.40 | 87,700 | 1,350,580 | 1,028,733 | 1.1 M to 1 M (-7.86 %) |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.75 | 4,600 | 72,450 | 1,116,433 | 1.1 M to 1.1 M (-0.41 %) |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.75 | 20,400 | 321,300 | 1,121,033 | 1.1 M to 1.1 M (-1.79 %) |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.69 | 24,600 | 386,011 | 1,141,433 | 1.2 M to 1.1 M (-2.11 %) |
| Jan 13 2006 | AVM | AMAG PHARMACEUTICA ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 15.69 | 109,100 | 1,711,943 | 1,166,033 | 1.3 M to 1.2 M (-8.56 %) |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | STEINMAN THEODORE I | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Nov 17 2005 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | Vice President | Option Exercise | A | 9.11 | 5,000 | 45,550 | 5,000 | |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Nov 17 2005 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President | Option Exercise | A | 9.10 | 250,000 | 2,275,000 | 250,000 | |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Nov 02 2005 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | A | 8.98 | 8,000 | 71,840 | 8,000 | |
| Jul 14 2005 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Option Exercise | A | 10.80 | 60,000 | 648,000 | 83,000 | |
| Jun 03 2005 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Option Exercise | P | 13.00 | 3,157 | 41,041 | 3,157 | |
| Jun 03 2005 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Buy | P | 0.00 | 15,785 | 0 | 15,785 | 0 to 15.8 K |
| May 04 2005 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel & VP Le ... | Option Exercise | A | 7.73 | 12,000 | 92,760 | 38,000 | |
| Mar 01 2005 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Vice President | Option Exercise | A | 20.32 | 26,000 | 528,320 | 26,000 | |
| Feb 03 2005 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | Vice President | Option Exercise | A | 16.80 | 4,000 | 67,200 | 4,000 | |
| Nov 15 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President & Tr ... | Gift | G | 0.00 | 250 | 0 | 156,287 | 156.5 K to 156.3 K (-0.16 %) |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | STEINMAN THEODORE I | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Nov 09 2004 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 13.55 | 8,000 | 108,400 | 8,000 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 9.40 | 1,700 | 15,980 | 6,300 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 5.14 | 5,000 | 25,700 | 0 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 3.85 | 2,500 | 9,625 | 2,500 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 3.20 | 5,000 | 16,000 | 5,000 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 3.05 | 10,000 | 30,500 | 0 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | M | 3.50 | 10,000 | 35,000 | 0 | |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 9.40 | 1,700 | 15,980 | 64,200 | 62.5 K to 64.2 K (+2.72 %) |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 5.14 | 5,000 | 25,700 | 62,500 | 57.5 K to 62.5 K (+8.70 %) |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 3.85 | 2,500 | 9,625 | 57,500 | 55 K to 57.5 K (+4.55 %) |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 3.20 | 5,000 | 16,000 | 55,000 | 50 K to 55 K (+10.00 %) |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 3.05 | 10,000 | 30,500 | 50,000 | 40 K to 50 K (+25.00 %) |
| Oct 15 2004 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | M | 3.50 | 10,000 | 35,000 | 40,000 | 30 K to 40 K (+33.33 %) |
| Nov 08 2004 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | P | 12.11 | 800 | 9,688 | 1,200 | 400 to 1.2 K (+200.00 %) |
| Nov 08 2004 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | P | 12.10 | 400 | 4,840 | 400 | 0 to 400 |
| Jul 28 2004 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
| Jul 23 2004 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Sell | S | 14.00 | 1,100 | 15,400 | 5,877 | 7 K to 5.9 K (-15.77 %) |
| Jul 23 2004 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Sell | S | 14.25 | 237 | 3,377 | 6,977 | 7.2 K to 7 K (-3.29 %) |
| Jul 14 2004 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | Chief Financial Off ... | Option Exercise | A | 14.70 | 10,000 | 147,000 | 10,000 | |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice-President | Buy | M | 3.96 | 1,500 | 5,940 | 11,799 | 10.3 K to 11.8 K (+14.56 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice-President | Buy | M | 3.96 | 1,500 | 5,940 | 11,799 | 10.3 K to 11.8 K (+14.56 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice President | Buy | M | 3.96 | 1,500 | 5,940 | 10,790 | 9.3 K to 10.8 K (+16.15 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Buy | M | 3.96 | 1,500 | 5,940 | 7,214 | 5.7 K to 7.2 K (+26.25 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | LAWLER DENNIS R | Vice President | Buy | M | 3.96 | 1,500 | 5,940 | 6,105 | 4.6 K to 6.1 K (+32.57 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | LAWLER DENNIS R | Vice President | Buy | M | 3.96 | 1,500 | 5,940 | 6,105 | 4.6 K to 6.1 K (+32.57 %) |
| Jun 02 2004 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice President | Buy | M | 3.96 | 1,500 | 5,940 | 8,729 | 7.2 K to 8.7 K (+20.75 %) |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Option Exercise | M | 5.65 | 6,250 | 35,338 | 18,750 | |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Option Exercise | M | 3.37 | 15,000 | 50,532 | 5,000 | |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Option Exercise | M | 4.40 | 20,000 | 88,000 | 0 | |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Buy | M | 5.65 | 6,250 | 35,338 | 546,903 | 540.7 K to 546.9 K (+1.16 %) |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Buy | M | 3.37 | 15,000 | 50,532 | 540,653 | 525.7 K to 540.7 K (+2.85 %) |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Buy | M | 4.40 | 20,000 | 88,000 | 525,653 | 505.7 K to 525.7 K (+3.96 %) |
| Feb 13 2004 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Payment of Exercise | F | 10.01 | 17,369 | 173,864 | 505,653 | 523 K to 505.7 K (-3.32 %) |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice President | Option Exercise | A | 10.87 | 3,000 | 32,610 | 3,000 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice President | Option Exercise | A | 10.87 | 3,000 | 32,610 | 3,000 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Option Exercise | A | 10.87 | 3,000 | 32,610 | 3,000 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice President | Option Exercise | A | 10.87 | 2,500 | 27,175 | 2,500 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Option Exercise | A | 10.87 | 3,000 | 32,610 | 3,000 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Option Exercise | A | 10.87 | 3,000 | 32,610 | 3,000 | |
| Feb 05 2004 | AVM | AMAG PHARMACEUTICA ... | LAWLER DENNIS R | Vice President | Option Exercise | A | 10.87 | 2,500 | 27,175 | 2,500 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice president | Option Exercise | M | 4.00 | 1,250 | 5,000 | 2,500 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice president | Option Exercise | M | 12.13 | 2,000 | 24,250 | 0 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice president | Buy | M | 4.00 | 1,250 | 5,000 | 7,229 | 6 K to 7.2 K (+20.91 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice president | Buy | M | 12.13 | 2,000 | 24,250 | 5,979 | 4 K to 6 K (+50.26 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice president | Payment of Exercise | F | 12.78 | 2,288 | 29,241 | 3,979 | 6.3 K to 4 K (-36.51 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Option Exercise | M | 3.06 | 2,000 | 6,125 | 10,000 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Option Exercise | M | 12.13 | 2,000 | 24,250 | 0 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Buy | M | 3.06 | 2,000 | 6,125 | 5,714 | 3.7 K to 5.7 K (+53.85 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Buy | M | 12.13 | 2,000 | 24,250 | 3,714 | 1.7 K to 3.7 K (+116.69 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Payment of Exercise | F | 12.78 | 2,376 | 30,365 | 1,714 | 4.1 K to 1.7 K (-58.09 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Option Exercise | M | 4.00 | 1,000 | 4,000 | 3,000 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Buy | M | 4.00 | 1,000 | 4,000 | 10,299 | 9.3 K to 10.3 K (+10.75 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Payment of Exercise | F | 12.78 | 238 | 3,042 | 9,299 | 9.5 K to 9.3 K (-2.50 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice Preisdent | Option Exercise | M | 3.06 | 3,000 | 9,188 | 9,000 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice Preisdent | Option Exercise | M | 4.00 | 1,250 | 5,000 | 3,750 | |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice Preisdent | Buy | M | 3.06 | 3,000 | 9,188 | 9,290 | 6.3 K to 9.3 K (+47.69 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice Preisdent | Buy | M | 4.00 | 1,250 | 5,000 | 6,290 | 5 K to 6.3 K (+24.80 %) |
| Nov 21 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice Preisdent | Payment of Exercise | F | 12.78 | 1,110 | 14,186 | 5,040 | 6.2 K to 5 K (-18.05 %) |
| Nov 05 2003 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | A | 9.40 | 8,000 | 75,200 | 48,000 | |
| Nov 05 2003 | AVM | AMAG PHARMACEUTICA ... | WHITESIDES GEORGE M | Director | Option Exercise | A | 9.40 | 8,000 | 75,200 | 68,000 | |
| Nov 05 2003 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 9.40 | 8,000 | 75,200 | 63,000 | |
| Nov 05 2003 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | A | 9.40 | 8,000 | 75,200 | 68,000 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | LAWLER DENNIS R | Vice President | Option Exercise | A | 8.42 | 2,000 | 16,840 | 2,000 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | LEWIS JEROME M | Vice President | Option Exercise | A | 8.42 | 2,500 | 21,050 | 2,500 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | MATHESON JAMES A | Vice President | Option Exercise | A | 8.42 | 2,500 | 21,050 | 2,500 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | JACOBS PAULA | Vice President | Option Exercise | A | 8.42 | 2,500 | 21,050 | 2,500 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Option Exercise | A | 8.42 | 3,000 | 25,260 | 3,000 | |
| Aug 14 2003 | AVM | AMAG PHARMACEUTICA ... | ROESSEL MARK C | Vice President | Option Exercise | A | 8.42 | 3,000 | 25,260 | 3,000 |